Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:43 PM
Ignite Modification Date:
2025-12-26 @ 10:43 PM
NCT ID:
NCT01560312
Eligibility Criteria:
Inclusion Criteria:
* Refractory hypertension with office SBP \> 140 mmHg
* SBP \> 130 during 24-hours Holter blood pressure monitoring
* Treatment with the least 3 antihypertensive medications including diuretics in optimal doses
* Age \> 18 years
* Signed informed consent
Exclusion Criteria:
* Secondary forms of hypertension
* Chronic renal disease (serum creatinine \> 200 umol/l)
* Pregnancy
* History of myocardial infarction or stroke in last 6 months
* Severe valvular stenotic disease
* Anatomic abnormalities and variants of renal artery including aneurysms, severe stenosis, reference diameter \< 4 mm or length \< 20 mm
* Increased bleeding risk (thrombocytopenia \< 50, INR \> 1.5)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01560312
Study Brief:
Protocol Section:
NCT01560312